Molecular basis of mature T-cell leukemia.

T-cell chronic lymphocytic/prolymphocytic leukemia (T-CLL/T-PLL) is a lymphoproliferative disease derived from immunocompetent post-thymic T cells. Activation (initiation of expression) of the TCL1 locus at chromosome 14q32.1 appears to be the causal event in the pathogenesis of these mature T-cell leukemias. This activation occurs as a result of translocations or inversions that cause rearrangement of the TCL1 (T-cell leukemia/lymphoma 1) locus with regulatory elements of T-cell receptor genes. To describe the molecular events that take part in the leukemogenesis of mature T-cell leukemias, we reviewed the literature and our own data on the molecular basis of mature T-cell leukemia. This data search revealed that 4 genes have been identified at the TCL1 locus: TCL1, TCL1b, TNG1, and TNG2. The expression of these genes is substantially increased following rearrangements involving 14q32.1. Functional analysis of the Tcl1 protein revealed its involvement in an Akt (protein kinase B) prosurvival pathway through its interaction with the Akt kinase, which promotes translocation of Akt to the nucleus and increases Akt's enzymatic activity. The available data provide important insights into the molecular mechanisms of T-cell leukemogenesis that may lead to the development of new drugs for treatment of mature T-cell leukemia.

[1]  D. Catovsky,et al.  High remission rate in T-cell prolymphocytic leukemia with CAMPATH-1H. , 2001, Blood.

[2]  N. Masuyama,et al.  Akt Inhibits the Orphan Nuclear Receptor Nur77 and T-cell Apoptosis* , 2001, The Journal of Biological Chemistry.

[3]  C. Sawyers,et al.  Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. , 2001, The New England journal of medicine.

[4]  D. Catovsky,et al.  TCL1 is activated by chromosomal rearrangement or by hypomethylation , 2001, Genes, chromosomes & cancer.

[5]  David J Rawlings,et al.  TCL1 Oncogene Expression in B Cell Subsets from Lymphoid Hyperplasia and Distinct Classes of B Cell Lymphoma , 2001, Laboratory Investigation.

[6]  Y. Pekarsky,et al.  Akt phosphorylates and regulates the orphan nuclear receptor Nur77 , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[7]  E. Tabolacci,et al.  Telomeric associations and chromosome instability in ataxia telangiectasia T cells characterized by TCL1 expression. , 2001, Cancer genetics and cytogenetics.

[8]  J. Laine,et al.  The protooncogene TCL1 is an Akt kinase coactivator. , 2000, Molecular cell.

[9]  M. Isobe,et al.  Identification of the TCL6 genes within the breakpoint cluster region on chromosome 14q32 in T-cell leukemia , 2000, Oncogene.

[10]  C D Baroni,et al.  Regulation of TCL1 expression in B- and T-cell lymphomas and reactive lymphoid tissues. , 2000, Cancer research.

[11]  Y. Pekarsky,et al.  Genomic analysis of human and mouse TCL1 loci reveals a complex of tightly clustered genes. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[12]  K. Moelling,et al.  Phosphorylation and regulation of Raf by Akt (protein kinase B). , 1999, Science.

[13]  L. Pfeffer,et al.  NF-κB activation by tumour necrosis factor requires the Akt serine–threonine kinase , 1999, Nature.

[14]  C. Denny,et al.  TCL1 oncogene expression in AIDS-related lymphomas and lymphoid tissues. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[15]  M. Isobe,et al.  Identification of the TCL1/MTCP1-like 1 (TML1) gene from the region next to the TCL1 locus. , 1999, Cancer research.

[16]  C. Croce.  Role of TCL1 and ALL1 in human leukemias and development. , 1999, Cancer research.

[17]  Y. Pekarsky,et al.  Abnormalities at 14q32.1 in T cell malignancies involve two oncogenes. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[18]  D. Kioussis,et al.  Bad Can Act as a Key Regulator of  T Cell Apoptosis and T Cell Development , 1999, The Journal of experimental medicine.

[19]  F. Sigaux,et al.  Transgenic mice for MTCP1 develop T-cell prolymphocytic leukemia. , 1998, Blood.

[20]  Masao Seto,et al.  Expression of the TCL1 Gene at 14q32 in B‐Cell Malignancies but Not in Adult T‐Cell Leukemia , 1998, Japanese journal of cancer research : Gann.

[21]  M. Isobe,et al.  Amplification of the TCL1 flanking region at 14q32.1 with no TCL1 gene transcription in a patient with peripheral T cell lymphoma , 1998, Leukemia.

[22]  G. Russo,et al.  Deregulated expression of TCL1 causes T cell leukemia in mice. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[23]  G. Russo,et al.  TCL1 is overexpressed in patients affected by adult T-cell leukemias. , 1997, Cancer research.

[24]  J. Milbrandt,et al.  Differential Regulation of the Transcriptional Activity of the Orphan Nuclear Receptor NGFI-B by Membrane Depolarization and Nerve Growth Factor* , 1997, The Journal of Biological Chemistry.

[25]  F. Chan,et al.  Functional redundancy of the Nur77 and Nor‐1 orphan steroid receptors in T‐cell apoptosis , 1997, The EMBO journal.

[26]  W. Siegert,et al.  Chronic lymphatic leukemias of T and NK cell type. , 1997, Leukemia.

[27]  M. Dyer,et al.  Expression of either the TCL1 oncogene, or transcripts from its homologue MTCP1/c6.1B, in leukaemic and non-leukaemic T cells from ataxia telangiectasia patients. , 1996, Oncogene.

[28]  A. Taylor,et al.  Leukemia and lymphoma in ataxia telangiectasia. , 1996, Blood.

[29]  M. Isobe,et al.  TCL1 oncogene activation in preleukemic T cells from a case of ataxia-telangiectasia. , 1995, Blood.

[30]  M. Isobe,et al.  Identification of the TCL1 gene involved in T-cell malignancies. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[31]  G. Russo,et al.  Characterization and localization of the TCL-1 oncogene product. , 1994, Cancer research.

[32]  M. Caligiuri,et al.  ALL-1 partial duplication in acute leukemia. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[33]  M. Isobe,et al.  Chromosome walking on the TCL1 locus involved in T-cell neoplasia. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[34]  F. Sigaux,et al.  MTCP-1: a novel gene on the human chromosome Xq28 translocated to the T cell receptor alpha/delta locus in mature T cell proliferations. , 1993, Oncogene.

[35]  J. Blenis,et al.  Functional domains and phosphorylation of the orphan receptor Nur77. , 1993, Molecular endocrinology.

[36]  D. Catovsky,et al.  Clinical and laboratory features of 78 cases of T-prolymphocytic leukemia. , 1991, Blood.

[37]  T. Rabbitts.  Translocations, master genes, and differences between the origins of acute and chronic leukemias , 1991, Cell.

[38]  D. Catovsky,et al.  Inversions and tandem translocations involving chromosome 14q11 and 14q32 in T-prolymphocytic leukemia and T-cell leukemias in patients with ataxia telangiectasia. , 1991, Cancer genetics and cytogenetics.

[39]  C. Croce.  Role of chromosome translocations in human neoplasia , 1987, Cell.

[40]  J Erikson,et al.  Differential expression of the translocated and the untranslocated c-myc oncogene in Burkitt lymphoma. , 1983, Science.

[41]  J. Stephenson,et al.  A cellular oncogene is translocated to the Philadelphia chromosome in chronic myelocytic leukaemia , 1982, Nature.

[42]  J. Hartley,et al.  Isolation of transforming murine leukemia viruses from mice with a high incidence of spontaneous lymphoma. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[43]  D. Catovsky.  Chronic lymphoproliferative disorders. , 1995, Current opinion in oncology.